CARMAT announces the first commercial implant of its Aeson artificial heart

19 July 2021 - 11:04 By Reuters
subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now

French artificial heartmaker CARMAT announced on Monday the first commercial implant of its Aeson artificial heart at a hospital in Italy, which the company said paved the way for its further commercial development.

Last week, CARMAT had announced the first human implant of its Aeson bioprosthetic artificial heart in the United States.

subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now